glp-1 and fertility The hidden impact of GLP‐1 receptor agonists on endometrial receptivity implantation - Sola‐Leyva - 2025 - Acta Obstetricia et Gynecologica Scandinavica How GLP-1 drug semaglutide may
Description
The plaintiffs allege that drugmaker Novo Nordisk didn't warn them about the risks of taking the medication
Promotes weight loss by mimicking a GLP-1 hormone
GLP-1 receptor agonist clinical trials surge, with semaglutide leading the way in obesity and type 2 diabetes treatmen
Primary care physicians often make decisions regarding the initiation of basal insulin in T2D, as they work closely with patients and are well placed to discuss and manage the transition to basal insulin therapy
